BI
Composite scorecard: 2/100 — Quality 2
| Share price | ₹62.02 |
| P/B ratio | 0.8 |
| ROE | -5.2% |
| Book value | ₹83.58 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹734 Cr | ₹-17 Cr | 6.0% |
| 2025 | ₹788 Cr | ₹-56 Cr | 6.0% |
| 2024 | ₹747 Cr | ₹-59 Cr | 5.0% |
| 2023 | ₹982 Cr | ₹50 Cr | 6.0% |
| 2022 | ₹845 Cr | ₹-4 Cr | 7.0% |
Bilcare Limited provides pharmaceutical packaging research solutions in India and internationally. The company offers aluminum foils, polymer films, and anti-counterfeiting packaging solutions for solid dosage pharmaceutical products and other applications; and blister films and foils, lidding foils, cr foils, and laminates. It also engages in the provision of clinical trial supplies, clinical trial management, and brand protection technologies services; and research and development services comprising formulation stability studies, blister/foil design and development, pharma brand innovation,